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1005-63 Initial Clinical Experience With an Intravascular 
Ultrasound-Guided Transmembrane Puncture Device to 
Facilitate Recanalization of Total Femoral Artery 
Occlusions
Dierk Scheinert, Andrej Schmidt, Susanne Scheinert, Sven Bräunlich, Giancarlo 
Biamino, Clinical and Interventional Angiology, Heart Center, Leipzig, Germany
Purpose: Failure to recanalize chronic superficial femoral artery occlusions is caused in
the majority of the cases by subintimal passage of the occlusion with inability to re-enter
the true lumen with the guide-wire. The present study details our initial experience with
the CrossPoint TransAccess crossing device (Transvascular Inc.) to facilitate recanaliza-
tion of total femoral artery occlusions.
Methods: 14 consecutive patients (11 male, mean age 63 years) who failed recanaliza-
tion attempts of chronic superficial femoral artery occlusions (mean occlusion length 12.7
cm) with standard techniques were re-scheduled for a secondary recanalization proce-
dure. The CrossPoint device is a 6.2F rapid exchange catheter, which tracks over an
0.014"-wire. A 20MHz phased array IVUS transducer is integrated into the tip of the cath-
eter allowing visualization of the vessel morphology. Using the guidance of the IVUS
crossectional image supported by colour-flow imaging the true lumen is punctured with
an integrated 24G needle allowing delivery of a second 0.014"-wire.
Results: Re-entry into the true lumen was successfully accomplished in all cases without
complications. In 4 cases with severe calcification predilatation of the false channel was
necessary to allow advancement of the CrossPoint device. Furthermore, in patients with
severe calcification multiple puncture attempts were necessary to penetrate the dissec-
tion membrane. A procedural success (<25% residual stenosis) could be achieved in all
cases after predilatation and stenting of the occlusion with selfexpanding nitinol stents.
Conclusion: The CrossPoint device is an effective and save tool to facilitate true lumen
re-entry during recanalization of total superficial femoral artery occlusions.
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Background: Percutaneous closure of patent foramen ovale (PFO) is an alternative to
surgical treatment of this defect. Transesophageal echocardiography (TEE) or intracar-
diac echocardiography (ICE) guidance is used for percutaneous placement of closure
devices. The use of general anesthesia during TEE or the use of ICE significantly
increases the cost of this procedure. We report our experience of PFO closure with Car-
dioSEAL using transeptal puncture without TEE or ICE guidance.
Methods: We report 29 consecutive patients (men 18, age 52±13, ejection fraction
60±3%) with cerebral embolic event and associated PFO treated with percutaneous Car-
dioSEAL placement using the transeptal approach. Previous data from 33 consecutive
patients using TEE or ICE guidance for PFO closure was used as a control group. The
CardioSEAL device was used in all patients. Procedural success was defined as suc-
cessful placement of the device. Follow-up transthoracic echocardiography (TTE) with
bubble study at 3 month was performed in all but one patient.
Results: Twenty-eight patients in the transeptal group presented with a cerebral embolic
event and 3 patients experienced extracranial embolic events. The CardioSEAL device
was successfully deployed in all 29 patients. There was no in-hospital mortality or throm-
boembolic event. All patients were discharged within 24 hours of the procedure. The
average device size was 29±2 mm. There was no significant difference between the
study group and the control in fluoroscopy time (9±5 vs 9.4±5 min, p=NS) and amount of
contrast used (136±60 vs 139±68 ml, p=NS). At a mean follow up of 69±58 days one
patient had atrial fibrillation, device associated thrombus, and a transient ischemic neuro-
logical event. Another patient committed suicide prior to follow-up. Four patients had int-
racardiac shunt detected by TTE with bubble contrast.
Conclusion: PFO closure using a blind transeptal technique without use of general anes-
thesia, TEE, or ICE guidance is a safe procedure without additional risks and cost. A
large randomized trial and longer follow-up is needed to determine if a blind transeptal
technique is comparable to echo guided techniques.
1005-65 Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO™) to Prevent Stroke in Patients 
With Atrial Fibrillation: Interim Results of the 
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Background: In order to prevent stroke in patients with AF and additional risk factors
who are suboptimal candidates for warfarine therapy, 103 persons have been enrolled in
the PLAATO™ Multicenter Trial so far (average age=71 yrs, 43-90 yrs; M/ F= 63/ 40).
Transcatheter occlusion prooved to be a safe procedure, nonetheless its benefit is still to
be discussed.
Methods: The risk of stroke for every patient enrolled in the PLAATO™ Multicenter Trial
was calculated according to the CHAD2 Risk Classification Scheme. Besides AF, this
scheme considers other stroke risk factors such as congestive heart failure, hypertension
(systolic >160 mm Hg), age greater than 75 years, diabetes and prior cerebral ischemia.
Results: Follow up tests have been performed in 101 patients that were enrolled in the
study (68,26 patient years). Most of the patients having several additional risk factors
besides AF, these were added to their personal CHAD2 Score, correlating with the
annual risk of stroke. The expected annual stroke rate without treatment was calculated
to be 5,3 % on the average (1,9 %-18,2 %). Two patients whose LAA was occluded suf-
fered from a stroke six month after implantation of the device. The annual stroke rate of
PLAATO™ patients was therefore calculated to be 2,9 % on the
average. In one case, there was no relation to the device or the implantation, in the other,
the relation is unknown.
Conclusions: As far as the interim follow up results show, transcatheter occlusion of the
LAA with the PLAATO™ device is not only a safe method, but seems to reduce the risk of
stroke in patients with AF.
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1006-55 In Vivo Macrophage Imaging of Acute Coronary 
Syndromes With Intracoronary Optical Coherence 
Tomography
Briain D. MacNeill, Ik Kyung Jang, Brett E. Bouma, Nicusor Iftimia, Masamichi Takano, 
Hiroshi Yabushita, Milen Shishkov, Guillermo J. Tearney, Massachusetts General 
Hospital, Boston, MA
Background: Atherosclerotic macrophage infiltration is a hallmark of coronary plaque
instability. Optical coherence tomography (OCT) is capable of imaging macrophages
within atherosclerotic plaque allowing quantitative and qualitative evaluation of coronary
inflammation.
Aim: To establish the pattern of macrophage infiltration in ST elevation myocardial infarc-
tion (STEMI) and other forms of acute coronary syndromes (ACS).
Methods & Results: We performed OCT at culprit sites and remote lesions in 38 patients
(19 STEMI, 19 ACS). A total of 95 lipid-rich plaques were analyzed. Macrophage density
was calculated as the normalized standard deviation (NSD) of the optical signal within
the superficial 50 microns of the fibrous cap. Macrophage heterogeneity was calculated
as the variance of the NSD. There was no significant difference in the macrophage den-
sity for STEMI and ACS groups (5.59 ± 1.70 %, 5.95 ± 1.88 %, P = NS). However, mac-
rophage heterogeneity was higher in the ACS group compared to the STEMI group (1.68
± 0.61 %, 2.1 ± 0.75 %, P = 0.007). Conclusion: Although the superficial macrophage
density is similar for both STEMI and ACS, the pattern of macrophage infiltration varies
significantly with a greater heterogeneity found in the ACS group.
Figure (A) OCT image of a lipid-rich plaque (LP) adjacent to a site of intimal disruption
(arrow). Scale bar = 500 µm; * represents guide wire shadow. (B) NSD image corre-
sponding to (A) demonstrating sites of high macrophage density (green to red).
1006-56 Virtual Histology of Intravascular Ultrasound Images: 
Feasibility and Clinical Correlations in Humans
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Virtual histology (VH, Volcano Therapeutics) uses spectral analysis of backscattered
intravascular ultrasound (IVUS) to classify plaque elements as calcium, fibrotic, fibrofatty,
or lipid core. Algorithms have been derived and validated in vitro. We report the first in
vivo studies (68 native arteries in 50 pts). ECG-gated, motorized pullback IVUS images
are analyzed. External elastic membrane (EEM) and lumen borders are identified by
automatic edge detection; plaque&media is “separated” into its components. Results:
The length analyzed was 44±24mm (2.4±0.6 frames/mm). Total segment (lesion+refer-
ence) EEM volume was 539±317mm3, lumen was 256±159mm3, plaque&media was
283±176mm3, and %obstruction was 51±9%; calcium was 2±3%, fibrotic plaque
31±14%, fibrofatty plaque 14±16%, and lipid core 12±8% of total plaque&media volume.
When compared to pt characteristics, %total segment calcium was greater in stable
